Medical and Organizational Challenges Resulting from a Radiological Nuclear Emergency
The tremendous environmental, social, and medical cost of a large-scale release of nuclear or radiological material as a result of deliberate attack or natural disaster has led to several programs aimed at improving national and local preparedness. Topics to be discussed around the mitigation and treatment of radiation damage include: patient assessment, biomarkers and biodosimetry, suitability of animal models, small molecules, growth factors, and cells as mitigators, as well as their mechanisms of action in radiation-damaged tissues, late effects of acute and prolonged exposure, survivorship issues, and future developments. Attendees will leave the conference armed with the information needed to improve their center’s preparedness for an emergency situation.
Physicians and other health care professionals who may care for patients with radiation damage.
At the conclusion of this activity, I will be able to:
- Discuss progress in research on radiological countermeasures and biodosimetry.
- Explain best practices from RITN hospitals.
- Evaluate medical and societal effects from a pertinent recent event.
- Describe federal objectives for radiological/nuclear disaster response.
- Identify key lessons from a real-world ARS treatment case study.
|Michael Epperly, PhD||Patent issued for use of JP4-039 as a radiation mitigator||Research|
|Lewis Rubinson, MD, PhD||FDA/Barda|
|Zoya Gluzman-Poltorak, PhD, MBA||Neumedicines||Employment|
|William Blakely, PhD||Meso Scale Diagnostics||Research|
|Joel Greenberger, MD||Patent issued for use of JP4-039 as a radiation mitigator||Research|
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved
- 9.50 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 9.50 Hours of ParticipationHours of Participation credit.